Skip to main content

180 Wealth Advisors, LLC

SEC CIK
0001730817
Latest filing
Jul 7, 2026

DNA holding history

Ginkgo Bioworks Holdings, Inc. in every 13F filed by 180 Wealth Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNA overviewAll 13F holders of DNAFull Q2 2026 holdings

Shares (Q3 2024)
0
Sold out in Q3 2024
Value
$0
% of portfolio
0.0%
Quarters held
11
Since Q4 2021
Holdings of DNA by 180 Wealth Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20240$00.0%−545−100.0%Sold outConverted for a 1-for-40 splitHolders
Q2 202421,810$6.98K<0.1%−3,829−14.9%ReducedHolders
Q1 202425,639$29.7K<0.1%+156+0.6%AddedHolders
Q4 202325,483$42.6K<0.1%−1,681−6.2%ReducedHolders
Q3 202327,164$49.2K<0.1%+214+0.8%AddedHolders
Q2 202326,950$48.0K<0.1%−2,720−9.2%ReducedHolders
Q1 202329,670$39.5K<0.1%−120.0%ReducedHolders
Q4 202229,682$51.9K<0.1%+1,104+3.9%AddedHolders
Q3 202228,578$89.0K<0.1%−1,516−5.0%ReducedHolders
Q2 202230,094$72.0K<0.1%+3,733+14.2%AddedHolders
Q1 202226,361$101.0K<0.1%+13,714+108.4%AddedHolders
Q4 202112,647$67.0K<0.1%+12,647NewHolders